Prevalence and mortality rate of congestive heart failure in the United States

Schocken, Douglas D.; Arrieta, Martha I.; Leaverton, Paul E.; Ross, Eric A.

doi:10.1016/0735-1097(92)90094-4

Cited by 741 publications

(365 citation statements)

References 23 publications

Supporting

Mentioning

334

Contrasting

Unclassified

Order By: Relevance

“…All subjects were referred to the arrhythmia unit with complaints of palpitations. Subjects were separated into three groups according to severity of heart involvement by the Los Andes classification (15): class I = 14 subjects, class II = 24 subjects, and class III = 12 subjects. Clinical and laboratory data were assessed during a personal interview and by review of the medical records.…”

Section: Methodsmentioning

confidence: 99%

Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease

Benchimol-Barbosa

Barbosa-Filho

2009

Braz J Med Biol Res

View full text Add to dashboard Cite

Atrial fibrillation (AF) affects subjects with Chagas' disease and is an indicator of poor prognosis. We investigated clinical, echocardiographic and electrocardiographic variables of Chagas' disease in a long-term longitudinal study as predictors of a new-onset AF episode lasting >24 h, nonfatal embolic stroke and cardiac death. Fifty adult outpatients (34 to 74 years old, 62% females) staged according to the Los Andes classification were enrolled. During a follow-up of (mean ± SD) 84.2 ± 39.0 months, 9 subjects developed AF (incidence: 3.3 ± 1.0%/year), 5 had nonfatal stroke (incidence: 1.3 ± 1.0%/year), and nine died (mortality rate: 2.3 ± 0.8%/year). The progression rate of left ventricular mass and left ventricular ejection fraction was significantly greater in subjects who experienced AF (16.4 ± 20.0 g/year and -8.6 ± 7.6%/year, respectively) than in those who did not (8.2 ± 8.4 g/year; P = 0.03, and -3.0 ± 2.5%/year; P = 0.04, respectively). In univariate analysis, left atrial diameter ≥3.2 cm (P = 0.002), pulmonary arterial hypertension (P = 0.035), frequent premature supraventricular and ventricular contraction counts/ 24 h (P = 0.005 and P = 0.007, respectively), ventricular couplets/24 h (P = 0.002), and ventricular tachycardia (P = 0.004) were long-term predictors of AF. P-wave signal-averaged ECG revealed a limited long-term predictive value for AF. In chronic Chagas' disease, large left atrial diameter, pulmonary arterial hypertension, frequent supraventricular and ventricular premature beats, and ventricular tachycardia are long-term predictors of AF. The rate of left ventricular mass enlargement and systolic function deterioration impact AF incidence in this population.

show abstract

Section: Methodsmentioning

confidence: 99%

Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease

Benchimol-Barbosa

Barbosa-Filho

2009

Braz J Med Biol Res

View full text Add to dashboard Cite

show abstract

“…According to Hermann and Greenberg 5 , however, it is not known if this reflects a difference in the natural history of the disease or if it results from the influence of the underlying etiology or from gender-dependent res-ponse to treatment. Schocken et al 6 , in another population study, also found smaller mortality in women. In Chagas' disease, the male patients, who have greater impairment in ejection fraction (EF), also have the poorest prognosis compared to women 7,8 .…”

Section: The Role Of Gendermentioning

confidence: 84%

“…Independently from the risk of developing CAD, diabetes increases the risk of developing CHF, and this risk is at least double in women than in men 6,17 . The risk of CHF is increased five times when hypertension is associated with diabetes 5 .…”

Section: Presence Of Comorbiditymentioning

confidence: 99%

See 1 more Smart Citation

Prognostic factors in patients with congestive heart failure

Villacorta¹,

Mesquita²

1999

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

“…Left ventricular systolic dysfunction (LVSD) and impaired pulmonary function (IPF) are associated with significant morbidity and mortality,1, 2, 3, 4, 5, 6, 7 and prevalence of both conditions increases with age 1, 5, 8, 9, 10. While cardiovascular disease is a major cause of death in individuals with IPF,7 little is known about the relative impact and the joint association of LVSD and IPF in terms of risk for clinical outcomes.…”

Section: Introductionmentioning

confidence: 99%

Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS)

Waheed

Chaves

Gardin

et al. 2015

JAHA

View full text Add to dashboard Cite

BackgroundImpaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all‐cause mortality, and their impact on risk classification using a continuous net reclassification index.Methods and ResultsWe followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction <55%. IPF was defined as: forced expiratory volume in 1 second:forced vital capacity <70%, and predicted forced expiratory volume in 1 second <80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all‐cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5–3.0), 1.7 (1.4–2.1), and 3.2 (2.0–5.1) for HF; 1.8 (1.2–2.6), 1.4 (1.1–1.8), and 2.8 (1.7–4.7) for cardiovascular mortality; 1.3 (1.0–1.8), 1.7 (1.4–1.9), and 2.1 (1.5–3.0) for all‐cause mortality, and 1.6 (1.3–2.1), 1.7 (1.5–1.9), and 2.4 (1.7–3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF.ConclusionsWhile risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.

show abstract

Prevalence and mortality rate of congestive heart failure in the United States

Abstract: Congestive heart failure is a common problem in the U.S., with significant prevalence and mortality, both of which increase with advancing age. As the population of the U.S. becomes older, the health care impact of congestive heart failure will probably grow.

Cited by 741 publications

References 23 publications

Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease

Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease

Prognostic factors in patients with congestive heart failure

Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS)

Contact Info

Product

Resources

About